Works matching IS 27709183 AND DT 2024 AND VI 3 AND IP 3

Results: 9

Issue Information.

Published in:: Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.80
Publication type:: Article

Identification of a disulfidptosis‐related prognostic signature for prediction of the effect of treatment in patients with endometrial carcinoma.

Published in:

Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.120

By:

Peng, Lu;
Gao, Yuan;
Cao, Zifeng;
Pang, Yingxin

Publication type:

Article

Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning.

Published in:

Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.119

By:

Zhu, Enzhao;
Zhang, Linmei;
Wang, Jiayi;
Hu, Chunyu;
Jing, Qi;
Shi, Weizhong;
Xu, Ziqin;
Ai, Pu;
Dai, Zhihao;
Shan, Dan;
Ai, Zisheng

Publication type:

Article

Establishment of a humanized mouse model using steady‐state peripheral blood‐derived hematopoietic stem and progenitor cells facilitates screening of cancer‐targeted T‐cell repertoires.

Published in:

Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.118

By:

Xu, Yulin;
Shan, Wei;
Luo, Qian;
Zhang, Meng;
Huo, Dawei;
Chen, Yijin;
Li, Honghu;
Ye, Yishan;
Yu, Xiaohong;
Luo, Yi;
Huang, He

Publication type:

Article

MAPK4 facilitates angiogenesis by inhibiting the ERK pathway in non‐small cell lung cancer.

Published in:

Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.117

By:

Chen, Jing;
Yang, Jing;
Liu, Yufang;
Zhao, Xu;
Zhao, Juanjuan;
Tang, Lin;
Guo, Mengmeng;
Zhou, Ya;
Chen, Chao;
Li, Dongmei;
Wen, Zhenke;
Liang, Guiyou;
Xu, Lin

Publication type:

Article

Cardiovascular toxicity with CTLA‐4 inhibitors in cancer patients: A meta‐analysis.

Published in:

Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.116

By:

Liu, Huiyi;
Fu, Lu;
Jin, Shuyu;
Ye, Xingdong;
Chen, Yanlin;
Pu, Sijia;
Xue, Yumei

Publication type:

Article

Histone deacetylase 6 as a novel promising target to treat cardiovascular disease.

Published in:

Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.114

By:

Wu, Ya‐Xi;
Li, Bing‐Qian;
Yu, Xiao‐Qian;
Liu, Yu‐Lin;
Chui, Rui‐Hao;
Sun, Kai;
Geng, Dian‐Guang;
Ma, Li‐Ying

Publication type:

Article

Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes.

Published in:

Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.112

By:

Seth, Sahil;
Chen, Runzhe;
Liu, Yang;
Fujimoto, Junya;
Hong, Lingzhi;
Reuben, Alexandre;
Varghese, Susan;
Behrens, Carmen;
McDowell, Tina;
Soto, Luisa Solis;
Haymaker, Cara;
Weissferdt, Annikka;
Kalhor, Neda;
Wu, Jia;
Le, Xiuning;
Vokes, Natalie I;
Cheng, Chao;
Heymach, John V.;
Gibbons, Don L.;
Futreal, P. Andrew

Publication type:

Article

Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis.

Published in:

Cancer Innovation, 2024, v. 3, n. 3, p. 1, doi. 10.1002/cai2.109

By:

Song, Wenhua;
Zhang, Nan;
Lv, Tonglian;
Zhao, Yang;
Li, Guangping;
Tse, Gary;
Liu, Tong

Publication type:

Article